Pacira Pharmaceuticals's total assets for Q1 2025 were $1.59B, an increase of 2.13% from the previous quarter. PCRX total liabilities were $788.13M for the fiscal quarter, a 1.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.